← Every applicant
Glaxosmithkline FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| UTEBZINew drugJun 17, 2026TABLET, ORAL |
| BLUJEPANew drugMar 25, 2025TABLET, ORAL |
| OJJAARANew drugSep 15, 2023TABLET, ORAL |
| ZEJULANew drugApr 26, 2023TABLET, ORAL |
| JESDUVROQNew drugFeb 1, 2023TABLET, ORAL |
| BREXAFEMMENew drugJun 1, 2021TABLET, ORAL |
| JEMPERLINew drugApr 22, 2021INJECTABLE, INJECTION |